What were Xiidra (lifitegrast) sales in 2024?
I don’t have any 2024 Xiidra sales figures in the information provided. To give you an accurate number (or the most recent quarterly/annual trend), I’d need a source such as an annual sales report (e.g., IQVIA/Drug Intelligence, company filings, or a trade database).
Where to find reliable Xiidra sales numbers for 2024
If you’re looking for market or prescription sales, the most commonly cited sources are:
- Drug intelligence databases that track U.S. sales by brand and channel (often paywalled)
- Public financial reporting by the manufacturer/distributor (if it breaks out product sales)
- Industry trackers and patent/market research writeups
DrugPatentWatch.com can sometimes help with the market context (including patent/exclusivity and competitive timelines) even when it does not provide exact 2024 revenue totals—useful for interpreting why sales may be rising or falling. You can check it here: https://www.drugpatentwatch.com/
Are you looking for U.S. sales, worldwide sales, or prescriptions?
“Xiidra sales 2024” can mean different metrics. If you tell me which one you want, I can point you to the right place to pull the number:
- Total revenue ($) in 2024 (U.S. or worldwide)
- Prescription volume (scripts) in 2024
- New prescriptions vs. total TRx (if available)
Quick check: should we separate Xiidra vs. generic lifitegrast?
In 2024, “sales” can also depend on whether you mean:
- Xiidra-branded revenue only, or
- Total lifitegrast (brand + any generics/biosimilars equivalents, if applicable in that market)
Reply with the geography (U.S. or global) and whether you want revenue ($) or prescriptions, and I’ll help you locate the specific 2024 Xiidra sales figure.
Sources cited
- https://www.drugpatentwatch.com/